» Authors » Mekibib Kassa

Mekibib Kassa

Explore the profile of Mekibib Kassa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 78
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van Griensven J, van Henten S, Kibret A, Kassa M, Beyene H, Abdellati S, et al.
EBioMedicine . 2024 Nov; 110:105474. PMID: 39612653
Background: Targeted preventive strategies in persons living with HIV (PLWH) require markers to predict visceral leishmaniasis (VL). We conducted a longitudinal study in a HIV-cohort in VL-endemic North-West Ethiopia to...
2.
Taye B, Melkamu R, Tajebe F, Ibarra-Meneses A, Adane D, Atnafu S, et al.
Parasit Vectors . 2024 Oct; 17(1):431. PMID: 39407317
Background: Cutaneous leishmaniasis (CL) in Ethiopia and some parts of Kenya is predominantly caused by Leishmania aethiopica. While skin-slit (SS) microscopy is routinely used for CL diagnosis, more sensitive molecular...
3.
de Vrij N, Vandoren R, Ramadan K, Van Hul A, Ceulemans A, Kassa M, et al.
PLoS Negl Trop Dis . 2024 Sep; 18(9):e0012000. PMID: 39348450
Human immunodeficiency virus (HIV) co-infection is a major challenge for visceral leishmaniasis (VL) control, particularly in Ethiopia where the incidence of both pathogens is high. VL-HIV often leads to high...
4.
de Vrij N, Pollmann J, Rezende A, Ibarra-Meneses A, Pham T, Hailemichael W, et al.
Commun Biol . 2024 May; 7(1):524. PMID: 38702419
A large proportion of HIV-coinfected visceral leishmaniasis (VL-HIV) patients exhibit chronic disease with frequent VL recurrence. However, knowledge on immunological determinants underlying the disease course is scarce. We longitudinally profiled...
5.
van Henten S, Kassa M, Fikre H, Melkamu R, Mekonnen T, Dessie D, et al.
Open Forum Infect Dis . 2024 Apr; 11(4):ofae113. PMID: 38560600
Background: Diagnosis of cutaneous leishmaniasis (CL) usually relies on invasive samples, but it is unclear whether more patient-friendly tools are good alternatives for diverse lesions when used with polymerase chain...
6.
van Griensven J, van Henten S, Kibret A, Kassa M, Beyene H, Abdellati S, et al.
Clin Infect Dis . 2024 Jan; 79(1):240-246. PMID: 38193647
Background: People with human immunodeficiency virus (PWH) with recurrent visceral leishmaniasis (VL) could potentially drive Leishmania transmission in areas with anthroponotic transmission such as East Africa, but studies are lacking....
7.
Amare G, Mekonnen G, Kassa M, Addisu A, Kendie D, Tegegne B, et al.
Parasit Vectors . 2023 Dec; 16(1):457. PMID: 38104111
Background: Leishmaniasis is a common neglected tropical disease in Ethiopia. Visceral leishmaniasis (VL) caused by Leishmania donovani presents in the lowlands, while cutaneous leishmaniasis (CL) affects people living in the...
8.
van Henten S, Pareyn M, Tadesse D, Kassa M, Techane M, Kinfe E, et al.
Front Med (Lausanne) . 2023 Oct; 10:1196063. PMID: 37886367
Background: Cutaneous leishmaniasis (CL) is a common, yet massively underreported skin morbidity in Ethiopia. Most patients never seek treatment, as this is offered only in specialized treatment centers. Early diagnosis...
9.
Melkamu R, Berhane N, Jacobs B, Mohammed R, Kassa M, Yeshanew A, et al.
PLoS Negl Trop Dis . 2023 Feb; 17(2):e0011128. PMID: 36780561
Background: As untreated visceral leishmaniasis (VL) is fatal, reliable diagnostics are pivotal for accurate treatment allocation. The current diagnostic algorithm for VL in Ethiopia, which is based on the rK39...
10.
van Henten S, Fikre H, Melkamu R, Dessie D, Mekonnen T, Kassa M, et al.
PLoS Negl Trop Dis . 2022 Jan; 16(1):e0010143. PMID: 35041672
Background: Cutaneous leishmaniasis (CL) is common in Ethiopia, mainly affecting impoverished populations in rural areas with poor access to health care. CL is routinely diagnosed using skin slit smear microscopy,...